Navigation Links
Dior Eyewear
Part of the Octopus System which includes both the Starfish & Octopus3. The Starfish Heart Positioner simplifies cardiac positioning and minimizes the associated hemodynamic deterioration when compa
... fit in tight spaces easily? Introducing the Guida... innovation in mechanical tissue stabilization.,T...low-profile feet, innovative FlexLink technology, ...ability, and access to target vessels.,Include th...
The AB-180 iVAD*, implantable ventricular assist device, is a surgically implantable device used by cardiac surgeons. The inflow and outflow conduits are pre-attached to the VAD and anatomically posi
Datascope presents a unique new product for post-hemostasis puncture site management. Safeguard is the first product ever to combine a built-in inflatable bulb and a sterile dressing- providing adjus
Medicine Products:
(Date:9/5/2008)...risk is greatest for those overweight or obese at ...ws) -- Almost half of all American adults will dev...ir odds increase if they are obese in middle age, ...the painful condition increased as his or her body...y of North Carolina at Chapel Hill study. People w...
(Date:9/5/2008)...s say patients taking meds on Web site shouldn,t o... Sept. 5 (HealthDay News) -- The U.S. Food and Dru...te drugs being evaluated for potential safety issu...rs on a quarterly report, it means we have begun a...blem that requires further evaluation," Dr. Gerald...
(Date:9/5/2008)...Lung cancer risk prediction models are enhanced by...easuring DNA repair capacity, according to researc...f Texas M. D. Anderson Cancer Center in two comple... Cancer Prevention Research . , In the first st...nd unique results based on increased exposure to c...
(Date:9/4/2008)...AINS, N.Y., Sept. 5 /PRNewswire/ -- A groundbreaki..., mental and emotional status of,men, their shorte...and,medical needs will take place Wednesday, Septe...r the auspices of members of the Westchester,medic... Marianne J. Legato,M.D. and Lionel Tiger, Ph.D.,...
Breaking Medicine News(10 mins):Health News:Almost Half of Adults Will Develop Knee Osteoarthritis by 85 2Health News:FDA to List Drugs Under Review for Safety Issues 2Health News:Creating lung cancer risk models for specific populations refines prediction 2Health News:Creating lung cancer risk models for specific populations refines prediction 3
...ia’s Rajasthan are unable to find brides, as a res... excessive fluoride has given rise to several orth.../ 'I have two sons of marriageable age but all my...ailed due to the water problem,’ said Ramji Lal Ja...
... risk of cardiovascular disease or diabetes can be... to a research conducted by Nadine Sahyoun of the ...Clinical Nutrition has published the results of th...te three whole grain food servings a day, had a lo...
...ental Biology have uncovered some of the molecular...tween the neurons, that represent the structural a...s, the junction between two neurons is referred to...y of communication between the same. Storage and t...
...and colleagues say that mutation in CCR5 (cell sur...n but increases the risk of developing West Nile v...ness is caused due to a mosquito-borne virus. This...Institute of Allergy and Infectious Diseases (NIAI...
Other Medicine News:Health News:Polluted Water Prevents Men From Getting Married 2Health News:Novel Protein, Staufen2 Important In Maintenance Of Nerve Synapses 2Health News:CCR5 Mutation Confers Immunity Against HIV But Not Against West Nile Virus Illness 2
(Date:9/3/2008)...ional Vascular Disease Awareness Month, CHARLOTTE...rmaceuticals,LLC, a clinical-stage drug-developmen...ent of unmet medical needs, announced today that i...nical trial of its lead drug,candidate trans sodiu...5881,on the clinicaltrials.gov Website, is investi...
(Date:9/3/2008)... Multaq(R) (dronedarone) decreased the risk of,str...atrial flutter already adequately tre..., Sept. 3 /- The results of...tudy were presented today at,the clinical trial up...,congress 2008, in Munich, Germany. Previous resul...
(Date:9/3/2008)...firms Strong Evidence Pycnogenol(R) Lowers Joint, ...nts Following Cessation ...ire/ -- According to the Center for,Disease Contro...rthritis,is on the rise. A new study published in...als Pycnogenol(R), bark extract from the French ma...
(Date:9/2/2008)...wswire-FirstCall/ -- Forest Laboratories, Inc.,(NY...nnounced results from,two global Phase III studies...d anticholinergic for the treatment of patients wi...n both the ACCLAIM/COPD I&II,(AClidinium CLinical ...,Severe COPD Patients) studies, once-daily aclidin...
Breaking Medicine Technology:Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 2Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 3Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 4Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 2Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 3Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 4Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 5Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 6Rhode Island Hospital to study driving ability of cognitively impaired elders 8483 1Breast Cancer Imaging Study Indicates Breast Specific Gamma Imaging 28BSGI 29 Is a Strong Adjunct Imaging Modality to Mammography and Ultrasound 8479 1Breast Cancer Imaging Study Indicates Breast Specific Gamma Imaging 28BSGI 29 Is a Strong Adjunct Imaging Modality to Mammography and Ultrasound 8479 2Breast Cancer Imaging Study Indicates Breast Specific Gamma Imaging 28BSGI 29 Is a Strong Adjunct Imaging Modality to Mammography and Ultrasound 8479 3Stryker to Present at Investor Conferences 8474 1Stryker to Present at Investor Conferences 8474 2Medco Chooses AllPoints at Anson in Whitestown Indiana as Site for the Worlds Largest Most Advanced Automated Pharmacy 2271 1Medco Chooses AllPoints at Anson in Whitestown Indiana as Site for the Worlds Largest Most Advanced Automated Pharmacy 2271 2Medco Chooses AllPoints at Anson in Whitestown Indiana as Site for the Worlds Largest Most Advanced Automated Pharmacy 2271 3Medco Chooses AllPoints at Anson in Whitestown Indiana as Site for the Worlds Largest Most Advanced Automated Pharmacy 2271 4Medco Chooses AllPoints at Anson in Whitestown Indiana as Site for the Worlds Largest Most Advanced Automated Pharmacy 2271 5
...lot Study Demonstrates 50% Survival in Valortim-Tr..., March 29, 2007 - Medarex,Inc. (Nasdaq: MEDX), a...ene, Inc., a privately held biotechnology company ...measures, today announced,that Valortim, a fully h...eveloped for the prevention and treatment of anthr...
...LLEGEVILLE, Pa., March 30, 2007 /PRNewswire-FirstC... , Solvay,Pharmaceuticals, Inc. and Lundbeck A/S p...n international medical congress this,week. Safety...reatment for adult patients diagnosed with schizop... lipid profile, similar to,placebo. In addition, i...
Other Medicine Technology:Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 2Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 3Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 4Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 5Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 6Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 7Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo 2Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo 3Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo 4Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo 5Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo 6